Douglas Rochler, 52, of Melville, New York has filed a lawsuit against the manufacturers of Zantac, a drug he believed caused him to develop bladder cancer complications. Rochler has undergone several surgeries due to cancer, and this has left him with long-term injuries. He has now filed a product liability lawsuit against the manufacturers of the drug that, according to him, was the genesis of his ailments.
Zantac, a popular heartburn drug, was pulled from the market in early April after regulators discovered that the drug produces NDMA, considered a carcinogen. Zantac, a brand name for ranitidine, has been a top-selling medication for heartburn and acid reflux for many years. Only until recently, many versions of Zantac have been recalled due to their high risks of causing cancer.
In a lawsuit filed on April 21 in the Southern District of Florida, Rochler and his wife, Anna Maria claim that the manufacturers of Zantac were aware of the drug’s production of a toxic carcinogen when taken but did not release this information to the patients or the U.S. Food and Drug Administration (FDA).
The lawsuit is one of many filed against the manufacturers by consumers who may have also been affected by the drug. Rochler and Maria are seeking compensation for medical expenses, lost earnings, pain, and suffering as well as the legal fees. Those named in the lawsuit include;
- GlaxoSmithKline- Manufactured and marketed Zantac between 1983 and 2009
- Boehringer Ingelheim Pharmaceuticals – Manufactured and marketed over-the-counter Zantac product between 2006 and 2017 in the United States
- Sanofi – Controls the U.S. rights to over-the-counter Zantac since January of 2017 to date.